| Article Access Statistics|
| Viewed||1209 |
| Printed||56 |
| Emailed||0 |
| PDF Downloaded||9 |
| Comments ||[Add] |
|Year : 2022
: 24 | Issue : 112 | Page
|Distortion Product Otoacoustic Emissions in Screening for Early Stages of High-frequency Hearing Loss in Adolescents
Danique E Paping1, Marc van der Schroef1, Hiske W Helleman2, André Goedegebure3, Rob J Baatenburg de Jong3, Jantien L Vroegop3
1 Department of Otorhinolaryngology, Speech and Hearing Centre, Erasmus University Medical Center, Rotterdam; The Generation R Study Group, Erasmus University Medical Center, Rotterdam, The Netherlands
2 Department of Otorhinolaryngology, University Medical Center Utrecht, Utrecht, The Netherlands
3 Department of Otorhinolaryngology, Speech and Hearing Centre, Erasmus University Medical Center, Rotterdam, The Netherlands
Click here for correspondence address
|Date of Submission||25-May-2021|
|Date of Decision||30-Nov-2021|
|Date of Acceptance||03-Dec-2021|
|Date of Web Publication||26-May-2022|
Objective: Adolescents may be at risk of noise-induced hearing loss due to recreational sound. The aim of this study was to examine the role of distortion product otoacoustic emissions (DPOAEs) in screening for early stages of high-frequency loss such as can be observed in noise-induced hearing loss. Setting and design: This cross-sectional study was embedded within Generation R, an ongoing prospective birth cohort study in Rotterdam, The Netherlands. Data were collected from April 2016 to September 2019. Methods: A total of 3456 adolescents with a mean age of 13 years and 8 months old (standard deviation ± 5 months) were included. Pure-tone thresholds were measured in a sound-treated booth. DPOAEs were recorded using an ILO V6 analyzer with primary levels of 65/55 dB SPL and frequency ratio f2/f1 of 1.22. Subjects had normal middle ear function at the time of assessment, based on tympanometry results. Results: Measurements in 6065 ears showed that DPOAE levels tend to decrease with increasing pure-tone thresholds. However, the intersubject variability of DPOAE levels in ears with the same threshold was large. DPOAE levels could reasonably identify early stages of high-frequency hearing loss. Conclusion: The findings of present study indicate that DPOAE measurements can potentially be used for adolescents hearing screening in the high frequencies. Future research is needed to optimize test performance.
Keywords: Adolescents, distortion product otoacoustic emissions, noise-induced hearing loss, screening
|How to cite this article:|
Paping DE, van der Schroef M, Helleman HW, Goedegebure A, Baatenburg de Jong RJ, Vroegop JL. Distortion Product Otoacoustic Emissions in Screening for Early Stages of High-frequency Hearing Loss in Adolescents. Noise Health 2022;24:20-6
|How to cite this URL:|
Paping DE, van der Schroef M, Helleman HW, Goedegebure A, Baatenburg de Jong RJ, Vroegop JL. Distortion Product Otoacoustic Emissions in Screening for Early Stages of High-frequency Hearing Loss in Adolescents. Noise Health [serial online] 2022 [cited 2023 Feb 2];24:20-6. Available from: https://www.noiseandhealth.org/text.asp?2022/24/112/20/345959
| Introduction|| |
There is widespread concern that the prevalence of acquired hearing loss in adolescents is rising, due to an increase in recreational noise exposure.,, Adolescents may be unaware or oblivious to the potential harm caused by excessive noise exposure., Noise can cause a broad set of metabolic and structural changes in the cochlea, changes that can eventually lead to irreversible hearing loss. By identifying hearing deficits in an early stage, progression can possibly be prevented and adverse effects minimized. Thereby, the individual and global burden of hearing loss can be reduced.
Distortion product otoacoustic emissions (DPOAEs) are widely used to study cochlear function. They are a by-product of the cochlear amplifier, which can be recorded in the ear canal in response to two closely spaced stimulus tones. DPOAEs reflect the integrity of the outer hair cells, essential for hearing sensitivity, and frequency selectivity. The presence of DPOAEs is generally associated with normal hearing, and is reduced or absent in individuals with hearing loss.,, It is this close relationship between DPOAEs and cochlear status that has driven the clinical application of DPOAEs for screening purposes. Moreover, DPOAEs have the advantages of being fast and easy to obtain, and require minimal behavioral response.
The DPOAEs are primary in use in universal newborn hearing screening programs, with the aim of detecting congenital hearing loss as soon as possible, and additionally in diagnostic settings. In adults, DPOAEs have been shown to accurately identify hearing loss in the mid and high frequencies, particularly for hearing losses between 20 and 30 dB hearing level (HL)., Although many studies have examined the performance of DPOAEs as screening tool in infants and adults, large studies in adolescents are not available. As reduced emission levels have been reported with increasing age,, the results found in the adult population cannot simply be extrapolated to other age groups. To bridge the knowledge gap between infants and adults, we examined the test performance of DPOAEs specific to the adolescent population. We aimed to examine the relationship between pure-tone thresholds and DPOAE levels in a large population-based cohort of 13-year adolescents. The focus of the study was on the ability of DPOAEs to detect early stages of high-frequency loss such as can be observed in noise-induced hearing loss.
| Methods|| |
Study design and population
This study was embedded in the Generation R Study, an ongoing multiethnic population-based prospective cohort from fetal life onward in Rotterdam, The Netherlands. The study was approved by the Medical Ethics Committee of Erasmus Medical Center and written informed consent was obtained from both parents of all participating children. Details on study design, response rate, and (loss to) follow-up have been published previously.
Adolescents aged 12 to 17 years were invited to the research center in the Erasmus Medical Center − Sophia Children’s Hospital to undergo hearing assessment. Subjects were eligible for inclusion if they completed DPOAE assessment and pure-tone audiometry. Tympanometry was performed to assess middle ear function. Subjects were excluded if they had an abnormal tympanogram, as described below. Data were collected from April 2016 to September 2019.
All subjects had middle ear function assessed for both ears, unless there was a contraindication such as excessive wax, otorrhea, acute otitis media, or recent ear surgery. Assessment of middle-ear function is of importance, as the transmission properties of the middle ear directly influence DPOAE characteristics. Tympanometry was conducted using an Interacoustics AT235h middle-ear analyzer with a 226-Hz probe tone. Ears with an ear canal volume smaller than 0.3 mL were excluded to avoid ear canal collapse or occlusive cerumen influencing the results. A compliance below 0.25 mL and/or middle ear pressure below −100 da Pascal were considered as abnormal as it could present external or middle ear pathology. Ears who had abnormal or missing tympanometry were excluded from the analyses.
Distortion product otoacoustic emissions
The DPOAEs were measured using an ILO V6 Analyzer and ILO probes with disposable tips. Calibration and a functional check of the probe were performed on a weekly basis. Adequacy of probe fit was checked before the start of data acquisition. DPOAEs were measured in response to two primary tones, presented simultaneously, at frequencies f1 and f2 and levels L1 and L2. The ratio of the two frequencies (f2/f1) was set at 1.22 as this ratio tends to produce the largest distortion products. The stimuli levels were held constant at L1 = 65 dB sound pressure level (SPL) and L2 = 55 dB SPL. Cubic distortion products (2 f1–f2) were measured at four points per octave, and the results were analyzed at the f2 frequencies 814 to 8000 Hz. Sampling at each test frequency continued until the noise floor was below −20 dB SPL. After 90 seconds, testing automatically stopped. Distortion products were plotted on a DP-Gram with the f2 frequency on the horizontal axis and the DPOAE amplitude of the 2 f1 − f2 distortion product (DPOAE level) on the vertical axis. The DPOAE level at each f2 frequency was chosen as the basic parameter to be correlated with the pure-tone threshold as it is a direct measure of cochlear function. The signal-to-noise ratio, on the other hand, is a composite measure that depends not only on the status of the cochlea but also on the measurement conditions, represented by the noise floor present during the recording.
To ensure noise levels were sufficiently low that even small emissions could be detected, a threshold criterion for the noise floor was used. This threshold criterion was determined from measurements in the cohort, namely two standard deviations above the average noise floor. The average noise floor across the frequency range 814 to 8000 kHz was calculated for each ear. When this value exceeded the cohort’s average noise floor plus two standard deviations, ears were excluded. Other reasons for exclusion were inadequate technical conditions for recording and research assistants, indicating uncertainty regarding correct insertion of the probes, that is, mistakenly changing the right and left ear probes.
Pure-tone audiometry was performed in a sound-treated booth meeting the maximum permissible ambient sound pressure levels of ISO standard 8253-1. Hearing thresholds were assessed using a clinical audiometer (Decos audiology workstation; version 210.2.6 with AudioNigma interface) and TDH-39P headphones with MX-41/AR ear cushions, calibrated every 12 months. Air conduction pure-tone thresholds were obtained at the frequencies 0.5, 1, 2, 3, 4, 6, and 8 kHz. Due to time constraints, no bone conduction thresholds were measured. Testing began at 20 dB HL. The level was reduced by 10 dB HL or increased by 5 dB HL according to the presence or absence of a response. The actual threshold was set after two out of three responses were consistent. The right and left ears were randomly tested first.
Scatterplots were created to examine the relationship between pure-tone thresholds and DPOAE levels at the individual frequencies 3 to 8 kHz, the frequencies mainly affected by noise exposure. As the audiometric frequencies and f2 frequencies did not always correspond, we interpolated the DPOAE level at 3000 Hz from those at 2828 and 3364 Hz, and at 6000 Hz from 5657 and 6757 Hz. The frequencies between 3 and 8 kHz were also averaged, as Sisto et al. (2007) demonstrated that averaging over sufficiently large bandwidth is necessary to obtain a good correlation between DPOAE levels and pure-tone thresholds.
A receiver-operating characteristic (ROC) curve was constructed to evaluate the diagnostic utility of DPOAEs to identify ears with high-frequency hearing loss such as can be observed in noise-induced hearing loss. In a ROC curve, the true positive rate (proportion of abnormal hearing ears correctly classified as abnormal) is plotted against the false-positive rate (proportion of normal hearing ears incorrectly classified as abnormal). The mean DPOAE level across the frequencies 2828 to 8000 Hz was used to detect high-frequency hearing loss as measured by pure-tone audiometry. High-frequency hearing loss was defined as (1) a threshold of 15 dB HL or less at 0.5 and 1 kHz, and (2) an average threshold of 3, 4, 6, and 8 kHz >15 dB HL. The area under the curve (AUC) was used as overall measure of test performance. Statistical analyses were performed using SPSS version 24.0 [IBM SPSS Statistics software (version 24.0 for Windows)] for Windows software (SPSS Inc) and R version 3.6.1.
| Results|| |
Between April 2016 and September 2019, 4929 adolescents visited the research center. DPOAEs and pure-tone thresholds were measured in 7652 ears, of whom 6248 (81.7%) had normal middle ear function based on tympanometry results. Fifty-two ears (0.8%) were excluded due to inadequate technical conditions for recording or incorrect insertion of the probes, and 131 ears (2.1%) due to an average noise floor above the threshold criterion. A total of 3456 subjects and 6065 ears were included. There was an equal distribution between right and left ears. Subjects were on an average 13 years and 8 months old (standard deviation ±5 months), and 1773 (51.3%) were girls.
The cohort’s average pure-tone thresholds of right and left ears are demonstrated in [Figure 1]. The lowest (best) thresholds were observed at 1 kHz, and highest (poorest) thresholds at 8 kHz.
|Figure 1 The cohort’s average pure-tone thresholds (dB HL) of the right and left ears. The error bars represent ±1 standard deviation.|
Click here to view
Distortion product otoacoustic emissions
The average DPOAE level varied from ‒7.4 to 7.9 dB SPL across the frequency range 841 to 8000 Hz, with a peak observed at 1682 and 4757 Hz [Figure 2]. There was a high degree of variability in DPOAE levels, with standard deviation values ranging from 9.6 to 12.8 dB SPL. The average noise floor ranged from −13.2 to −1.3 dB SPL, with a standard deviation of 2.5 to 5.5 dB SPL. When ears with a pure-tone threshold >15 dB HL at any of the frequencies were excluded, the average DPOAE level varied from −5.9 to 7.9 dB SPL.
|Figure 2 The cohort’s average DPOAE level and noise floor as a function of f2 frequency. The shaded areas represent ±1 standard deviation. DPOAE, distortion product otoacoustic emission.|
Click here to view
Pure-tone audiometry and distortion product otoacoustic emissions
[Figure 3] shows the relationship between pure-tone thresholds and DPOAE levels at the frequencies 3, 4, 6, and 8 kHz, and the average of these frequencies. There were many data points with similar values, thereby plotted on top of each other. Boxplots of the DPOAE level for different groups of ears based on the pure-tone threshold are presented in Supplementary [Figure 5]. In general, DPOAE levels tend to decrease with increasing hearing threshold. However, the vertical dispersion of the data was large.
|Figure 3 Scatterplots of DPOAE level (dB SPL) as a function of pure-tone threshold (dB HL). Ears with a signal-to-noise ratio (SNR) ≥ 0 dB were presented black, and ears with a SNR < 0 dB in gray. DPOAE, distortion product otoacoustic emission.|
Click here to view
|Figure 5 (Supplementary) Boxplots of the DPOAE level for different groups of ears, based on the pure-tone threshold at the frequencies 3, 4, 6, and 8 kHz, and the average of these frequencies. DPOAE, distortion product otoacoustic emission.|
Click here to view
A ROC curve was constructed to evaluate the extent to which ears with high-frequency hearing loss could be distinguished based on the DPOAE level averaged across the frequencies 2828 to 8000 Hz, as demonstrated in [Figure 4]. A total of 251 (4.1%) ears fulfilled the criteria of high-frequency hearing loss. The test performance was acceptable, with an AUC of 0.747. [Table 1] displays the sensitivity and specificity at various cutoff points of DPOAE levels for detecting high-frequency hearing loss. In Supplementary [Table 2], the accuracy with which DPOAE levels can identify ears with high-frequency hearing loss when using other definitions of high-frequency hearing loss are presented.
|Figure 4 Receiver-operator characteristic curve for the presence of high-frequency hearing loss. The area under the curve is the graph. AUC, area under the curve.|
Click here to view
|Table 1 Sensitivity and specificity of DPOAEs for detecting high frequency hearing loss at different cutoff points|
Click here to view
|Table 2 (Supplementary) The accuracy with which distortion product otoacoustic emission levels can identify ears with high-frequency hearing loss using different criteria of high-frequency hearing loss|
Click here to view
| Discussion|| |
To our knowledge, this is the largest study to describe pure-tone thresholds and DPOAE levels in a population-based cohort of adolescents today. Several studies have reported normative data for DPOAEs in a smaller cohort of adolescents of the same age.,,, In these studies, including 31 to 229 subjects, higher DPOAE levels were found (5–15 dB SPL). A possible explanation is that the f2 frequency range differed, with no measurements at 814 and 8000 Hz in the previously described studies. The minimum DPOAE level of −7.4 dB SPL reported in this study was found at 8000 Hz. Despite the differences in level of emissions, the general pattern of the DP-gram was similar. The peak in DPOAE level around 1500 and 4500 Hz was observed by many other researchers, both in pediatric and adult populations.,,,,
When examining the relationship between DPOAEs and pure-tone thresholds, we found that DPOAE levels tend to decrease with increasing hearing level. However, there was a large intersubject variability of DPOAE levels in ears with the same threshold. Some of the variability may be attributed to the so-called fine structure; that is, a pattern of peaks and valleys in the 2 f1-f2 DPOAE amplitude.,, This fine structure is supposed to be the consequence of physiologic inferences between two difference sources of the cochlea generating the DPOAE response. Differences in fine structure, either in frequency location or magnitude, may cause variability in normal DPOAE responses. Middle-ear transmission characteristics may also explain part of variability observed in DPOAEs among normal hearing ears.
There is no consensus on the role of DPOAEs in the screening for noise-induced hearing loss.,,, In this study, we observed that DPOAEs could reasonably identify high-frequency hearing loss such as can be observed in noise-induced hearing loss. Whereas previous research demonstrated that DPOAEs are most effective for detecting hearing losses between 20 and 30 dB HL, the focus of present study was on identifing early stages of hearing loss., It is important to keep in mind that the number of ears with high-frequency hearing loss was relatively low due to young age of our study population. Moreover, we assumed any high-frequency hearing loss to be associated with excessive noise exposure. However, high-frequency hearing loss could also result from other causes such as hereditory factors and ototoxic drugs. In this cross-sectional study, no inferences can be made on the cause of detected hearing losses.
Evaluating hearing status with a single DPOAE test is difficult considering the large dispersion of DPOAE levels within a population. However, there might be potential for DPOAEs in monitoring hearing function, since then the change within a single subject is of importance, and not the value itself. Several investigators have even suggested that DPOAEs are more sensitive in detecting subclinical cochlear damage compared to pure-tone audiometry. This evidence is mainly predicated upon the observation of lower emission levels in noise-exposed subjects compared to nonexposed subjects, whereas pure-tone thresholds were within normal limits.,,, Although this implicates that DPOAE levels decrease before hearing thresholds increase, most of these findings were based on cross-sectional studies. For an actual predictive value, longitudinal studies are required.
Strengths and limitations
The current study was conducted as part of the Generation R Study. The strengths include the prospective design and large sample size. Hearing was assessed by dedicated research assistants with a small variance, resulting in a relatively homogenous setting. A limitation of the study is that no otoscopic examination and bone-conduction audiometry were performed due to time constraints, with hearing assessment being just one of the multiple measurements at the research center. Tympanometry was performed to identify middle ear pathology. Although tympanometry is a fairly sensitive and reliable technique in the diagnosis of middle-ear dysfunction, it is possible that middle-ear pathology was not detected by tympanometry and conductive hearing loss was incorrectly classified as sensorineural loss. Furthermore, to this point, we have assumed that any error is associated with DPOAE testing, as pure-tone audiometry is considered the gold standard. However, it is important to keep in mind that pure-tone audiometry has a test–retest variability of about 5 dB HL. It could be that normal hearing ears were incorrectly classified as hearing impaired, and the other way around. As it has long been known that the outer hair cells in the cochlea are vulnerable to excessive noise more recently, animal studies have demonstrated that noise can also damage the synapses between the inner hair cells and auditory nerve fibers, which is called cochlear synaptopathy., As cochlear synaptopathy can occur without affecting pure-tone thresholds and DPOAE level, it was outside the scope of this study.
DPOAEs and pure-tone thresholds within the Generation R study will be repeatedly measured, and longitudinal data that will become available in the future. We aim to investigate whether (i) DPOAE levels change with age, (ii) a decline in DPOAE levels can be observed with a deterioration of hearing, (iii) subjects with low emissions but normal hearing at baseline have decreased thresholds during follow-up, and (iv) the association between DPOAE levels and noise exposure.
| Conclusions|| |
Although a consistent relationship between pure-tone thresholds and DPOAE levels was found, the intersubject variability of DPOAE levels in ears with the same threshold was large. We observed that DPOAEs can reasonably identify slight to mild levels of high-frequency hearing loss such as can be observed in noise-induced hearing loss. Future research is needed to improve test performance, and determine the role of DPOAEs in predicting and monitoring hearing loss in this age group.
The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. The authors gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives, and pharmacies in Rotterdam.
Financial support and sponsorship
The general design of Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, ZonMw, The Netherlands Organization for Scientific Research (NWO), and the Ministry of Health, Welfare and Sport. The researchers are independent from the funders. The study sponsors had no role in the study design, data analysis, interpretation of data, or writing of this report.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Shargorodsky J, Curhan SG, Curhan GC et al.
Change in prevalence of hearing loss in US adolescents. JAMA 2010;304:772-8.
Henderson E, Testa MA, Hartnick C. Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths. Pediatrics 2011;127:e39-46.
Wang J, le Clercq CMP, Sung V et al.
Cross-sectional epidemiology of hearing loss in Australian children aged 11-12 years old and 25-year secular trends. Arch Dis Child 2018;103:579-85.
Vogel I, Brug J, Hosli EJ et al.
MP3 players and hearing loss: adolescents’ perceptions of loud music and hearing conservation. J Pediatr 2008;152:400-4.
Gilles A, Van Hal G, De Ridder D et al.
Epidemiology of noise-induced tinnitus and the attitudes and beliefs towards noise and hearing protection in adolescents. PLoS One 2013;8:e70297.
Henderson D, Bielefeld EC, Harris KC et al.
The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006;27:1-19.
Skarzynski H, Piotrowska A. Screening for pre-school and school-age hearing problems: European consensus statement. Int J Pediatr Otorhinolaryngol 2012;76:120-1.
Kemp DT, Brown AM. An integrated view of cochlear mechanical nonlinearities observable from the ear canal. In: Mechanics of Hearing. Springer 1983. p. 75-82. DOI: 10.1007/978-94-009-6911-7_9
Nobili R, Mammano F, Ashmore J. How well do we understand the cochlea? Trends in neurosciences 1998;21:159-67.
Dorn PA, Konrad-Martin D, Neely ST et al.
Distortion product otoacoustic emission input/output functions in normal-hearing and hearing-impaired human ears. J Acoust Soc Am 2001;110:3119-31.
Gorga MP, Neely ST, Ohlrich B et al.
From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss. Ear Hear 1997;18:440-55.
Lonsbury-Martin BL, Martin GK. The clinical utility of distortion-product otoacoustic emissions. Ear Hear 1990;11:144-54.
Gorga MP, Neely ST, Bergman B et al.
Otoacoustic emissions from normal‐hearing and hearing‐impaired subjects: distortion product responses. J Acoust Soc Am 1993;93:2050-60.
Dorn PA, Piskorski P, Keefe DH et al.
On the existence of an age/threshold/frequency interaction in distortion product otoacoustic emissions. J Acoust Soc Am 1998;104:964-71.
Kon K, Inagaki M, Kaga M. Developmental changes of distortion product and transient evoked otoacoustic emissions in different age groups. Brain Dev 2000;22:41-6.
Kooijman MN, Kruithof CJ, van Duijn CM et al.
The Generation R Study: design and cohort update 2017. Eur J Epidemiol 2016;31:1243-64.
Naeve SL, Margolis RH, Levine SC et al.
Effect of ear-canal air pressure on evoked otoacoustic emissions. J Acoust Soc Am 1992;91:2091-5.
Jerger J. Clinical experience with impedance audiometry. Arch Otolaryngol 1970;92:311-24.
Harris FP, Lonsbury-Martin BL, Stagner BB et al.
Acoustic distortion products in humans: systematic changes in amplitudes as a function of f2/f1 ratio. J Acoust Soc Am 1989;85:220-9.
Stover L, Gorga MP, Neely ST et al.
Toward optimizing the clinical utility of distortion product otoacoustic emission measurements. J Acoust Soc Am 1996;100:956-67.
Helleman HW, Eising H, Limpens J et al.
Otoacoustic emissions versus audiometry in monitoring hearing loss after long-term noise exposure − a systematic review. Scand J Work Environ Health 2018;44:585-600.
Whitehead ML, Lonsbury-Martin BL, Martin GK. The influence of noise on the measured amplitudes of distortion-product otoacoustic emissions. J Speech Hear Res 1993;36:1097-102.
le Clercq CMP, van Ingen G, Ruytjens L et al.
Music-induced hearing loss in children, adolescents, and young adults: a systematic review and meta-analysis. Otol Neurotol 2016;37:1208-16.
Sisto R, Chelotti S, Moriconi L et al.
Otoacoustic emission sensitivity to low levels of noise-induced hearing loss. J Acoust Soc Am 2007;122:387-401.
le Clercq CMP, Goedegebure A, Jaddoe VWV et al.
Association between portable music player use and hearing loss among children of school age in The Netherlands. JAMA Otolaryngol Head Neck Surg 2018;144:668-75.
Brook L, Trussell J, Hilton K et al.
Normal values for distortion product otoacoustic emissions in children: a study using primary levels previously demonstrated to be optimum for identification of hearing loss. Scand Audiol 2001;30:37-43.
Pavlovčinová G, Jakubíková J, Trnovec T et al.
A normative study of otoacoustic emissions, ear asymmetry, and gender effect in healthy schoolchildren in Slovakia. Int J Pediatr Otorhinolaryngol 2010;74:173-7.
Groh D, Pelanova J, Jilek M et al.
Changes in otoacoustic emissions and high-frequency hearing thresholds in children and adolescents. Hear Res 2006;212:90-8.
Lonsbury-Martin BL, Harris FP, Hawkins MD et al.
Distortion product emissions in humans: I. Basic properties in normally hearing subjects. Ann Otol Rhinol Laryngol 1990;99:3-14.
Smurzynski J, Kim DO. Distortion-product and click-evoked otoacoustic emissions of normally-hearing adults. Hear Res 1992;58:227-40.
Mauermann M, Uppenkamp S, van Hengel PWJ et al.
Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. I. Fine structure and higher-order DPOAE as a function of the frequency ratio f2/f1. J Acoust Soc Am 1999;106:3473-83.
Talmadge CL, Long GR, Tubis A et al.
Experimental confirmation of the two-source interference model for the fine structure of distortion product otoacoustic emissions. J Acoust Soc Am 1999;105:275-92.
Heitmann J, Waldmann B, Plinkert PK. Limitations in the use of distortion product otoacoustic emissions in objective audiometry as the result of fine structure. Eur Arch Otorhinolaryngol 1996;253:167-71.
Shera CA, Guinan Jr JJ. Evoked otoacoustic emissions arise by two fundamentally different mechanisms: a taxonomy for mammalian OAEs. J Acoust Soc Am 1999;105:782-98.
Attias J, Bresloff I, Reshef I et al.
Evaluating noise induced hearing loss with distortion product otoacoustic emissions. Br J Audiol 1998;32:39-46.
Sliwinska-Kowalska M. The role of evoked and distortion-product otoacoustic emissions in diagnosis of occupational noise-induced hearing loss. Occupat Health Indust Med 1998;2:75.
Shupak A, Tal D, Sharoni Z et al.
Otoacoustic emissions in early noise-induced hearing loss. Otol Neurotol 2007;28:745-52.
Desai A, Reed D, Cheyne A et al.
Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise. Noise Health 1999;1:58-65.
] [Full text]
Attias J, Horovitz G, El-Hatib N et al.
Detection and clinical diagnosis of noise-induced hearing loss by otoacoustic emissions. Noise Health 2001;3:19-31.
] [Full text]
Balatsouras DG. The evaluation of noise-induced hearing loss with distortion product otoacoustic emissions. Med Sci Monit 2004;10:CR218-22.
LePage EL, Murray NM. Latent cochlear damage in personal stereo users: a study based on click‐evoked otoacoustic emissions. Med J Aust 1998;169:588-92.
Watters GWR, Jones JE, Freeland AP. The predictive value of tympanometry in the diagnosis of middle ear effusion. Clin Otolaryngol Allied Sci 1997;22:343-45.
Swanepoel DW, Mngemane S, Molemong S et al.
Hearing assessment—reliability, accuracy, and efficiency of automated audiometry. Telemed e-Health 2010;16:557-63.
Kujawa SG, Liberman MC. Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss. Hear Res 2015;330:191-9.
Kujawa SG, Liberman MC. Adding insult to injury: cochlear nerve degeneration after “temporary” noise-induced hearing loss. J Neurosci 2009;29:14077-85.
Barbee CM, James JA, Park JH et al.
Effectiveness of auditory measures for detecting hidden hearing loss and/or cochlear synaptopathy: a systematic review. Semin Hear 2018;39:172-209.
Danique E Paping
Department of Otorhinolaryngology, Speech and Hearing Centre, Erasmus Medical Centre, PO Box 2040, 3000 CA Rotterdam
Source of Support: None, Conflict of Interest: None
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2]